The Epidemiology of Work-Related Asthma

Immunology and Allergy Clinics of North America

Volumn 31, Issue 4, 2011, Pages 663-675

  Smith, Andrew M ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Asthma; Bronchospasm; Epidemiology; Workplace

Indexed keywords

ACID ANHYDRIDE; CHLORINE; DETERGENT; DIPHENYLMETHANE 4,4' DIISOCYANATE; DISINFECTANT AGENT; DOMESTIC CHEMICAL; HEXAMETHYLENE DIISOCYANATE; IMMUNOGLOBULIN E; LATEX; PARVALBUMIN; PHTHALIC ANHYDRIDE; TOBACCO SMOKE; TOLUENE DIISOCYANATE; TRIMELLITIC ANHYDRIDE; TROPOMYOSIN;

AIRWAY OBSTRUCTION; ASTHMA; DERMATOPHAGOIDES; DISEASE ASSOCIATION; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGICAL DATA; HEALTH HAZARD; HUMAN; INCIDENCE; INDUSTRIAL HYGIENE; IRRITANT INDUCED ASTHMA; MORBIDITY; OCCUPATIONAL ASTHMA; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH SERVICE; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTECTIVE CLOTHING; REVIEW; RISK ASSESSMENT; SCREENING TEST; SEA FOOD; SECONDARY PREVENTION; SENSITIZATION; WHEAT; WORK DISABILITY; WORK EXACERBATED ASTHMA;

ALLERGENS; ANIMALS; ASTHMA, OCCUPATIONAL; BRONCHIAL SPASM; DETERGENTS; EPIDEMIOLOGIC STUDIES; FLOUR; HUMANS; IMMUNOGLOBULIN E; IRRITANTS; ISOCYANATES; LATEX; MORBIDITY; OCCUPATIONAL EXPOSURE; POPULATION SURVEILLANCE; PYROGLYPHIDAE; SEAFOOD; UNITED STATES;

EID: 80053534979     PISSN: 08898561     EISSN: 15578607     Source Type: Journal    
DOI: 10.1016/j.iac.2011.07.009     Document Type: Review

References (62)

1. Breton C.V., Zhang Z., Hunt P.R., et al. Characteristics of work related asthma: results from a population based survey. Occup Environ Med 2006, 63(6):411-415.
2. Henneberger P.K., Derk S.J., Sama S.R., et al. The frequency of workplace exacerbation among health maintenance organisation members with asthma. Occup Environ Med 2006, 63(8):551-557.
3. Bernstein I.L. Asthma in the workplace, and related conditions 2006, Taylor & Francis, New York.
4. Bernstein D.I., Cartier A., Côté J., et al. Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma. Am J Respir Crit Care Med 2002, 166(4):445-450.
5. Brooks S.M., Hammad Y., Richards I., et al. The spectrum of irritant-induced asthma: sudden and not-so-sudden onset and the role of allergy. Chest 1998, 113(1):42-49.
6. Brooks S.M., Weiss M.A., Bernstein I.L. Reactive airways dysfunction syndrome (RADS). Persistent asthma syndrome after high level irritant exposures. Chest 1985, 88(3):376-384.
7. Medina-Ramon M., Zock J.P., Kogevinas M., et al. Short-term respiratory effects of cleaning exposures in female domestic cleaners. Eur Respir J 2006, 27(6):1196-1203.
8. Menzies D., Nair A., Williamson P.A., et al. Respiratory symptoms, pulmonary function, and markers of inflammation among bar workers before and after a legislative ban on smoking in public places. JAMA 2006, 296(14):1742-1748.
9. Newman Taylor A.J., Cullinan P., Burge P.S., et al. BOHRF guidelines for occupational asthma. Thorax 2005, 60(5):364-366.
10. Nicholson P.J., Cullinan P., Taylor A.J., et al. Evidence based guidelines for the prevention, identification, and management of occupational asthma. Occup Environ Med 2005, 62(5):290-299.
11. Tarlo S.M., Balmes J., Balkissoon R., et al. Diagnosis and management of work-related asthma: American College Of Chest Physicians Consensus Statement. Chest 2008, 134(Suppl 3):1S-41S.
12. Malo J.L., Ghezzo H., L'Archevêque J., et al. Is the clinical history a satisfactory means of diagnosing occupational asthma?. Am Rev Respir Dis 1991, 143(3):528-532.
13. Perkner J.J., Fennelly K.P., Balkissoon R., et al. Irritant-associated vocal cord dysfunction. J Occup Environ Med 1998, 40(2):136-143.
14. Balmes J., Becklake M., Blanc P., et al. American Thoracic Society Statement: occupational contribution to the burden of airway disease. Am J Respir Crit Care Med 2003, 167(5):787-797.
15. Blanc P.D., Toren K. How much adult asthma can be attributed to occupational factors?. Am J Med 1999, 107(6):580-587.
16. Kogevinas M., Zock J.P., Jarvis D., et al. Exposure to substances in the workplace and new-onset asthma: an international prospective population-based study (ECRHS-II). Lancet 2007, 370(9584):336-341.
17. Bakerly N.D., Moore V.C., Vellore A.D., et al. Fifteen-year trends in occupational asthma: data from the Shield surveillance scheme. Occup Med (Lond) 2008, 58(3):169-174.
18. Goe S.K., Henneberger P.K., Reilly M.J., et al. A descriptive study of work aggravated asthma. Occup Environ Med 2004, 61(6):512-517.
19. Rosenman K.D., Reilly M.J., Kalinowski D.J. A state-based surveillance system for work-related asthma. J Occup Environ Med 1997, 39(5):415-425.
20. Bateman E.D., Hurd S.S., Barnes P.J., et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008, 31(1):143-178.
21. Alert: preventing asthma and death from MDI exposure during spray-on truck bed liner and related applications 2006, NIOSH Publication 2006-149, NIOSH, Cincinnati (OH), p. 1-42.
22. Baur X. New aspects of isocyanate asthma. Lung 1990, 168(Suppl):606-613.
23. Karol M.H. Respiratory effects of inhaled isocyanates. Crit Rev Toxicol 1986, 16(4):349-379.
24. Kennedy A.L., Brown W.E. Isocyanates and lung disease: experimental approaches to molecular mechanisms. Occup Med 1992, 7(2):301-329.
25. Mapp C.E., Saetta M., Maestrelli P., et al. Low molecular weight pollutants and asthma: pathogenetic mechanisms and genetic factors. Eur Respir J 1994, 7(9):1559-1563.
26. Redlich C.A., Karol M.H. Diisocyanate asthma: clinical aspects and immunopathogenesis. Int Immunopharmacol 2002, 2(2-3):213-224.
27. Baur X., Marek W., Ammon J., et al. Respiratory and other hazards of isocyanates. Int Arch Occup Environ Health 1994, 66(3):141-152.
28. Bernstein J.A. Overview of diisocyanate occupational asthma. Toxicology 1996, 111(1-3):181-189.
29. A summary of health hazard evaluations: issues related to occupational exposure to isocyanates, 1989 to 2002 2004, DHHS (NIOSH) Publication No. 2004-116, NIOSH, Cincinnati (OH), p. 1-42.
30. Liu Y., Stowe M.H., Bello D., et al. Respiratory protection from isocyanate exposure in the autobody repair and refinishing industry. J Occup Environ Hyg 2006, 3(5):234-249.
31. Bernstein D.I., Korbee L., Stauder T., et al. The low prevalence of occupational asthma and antibody-dependent sensitization to diphenylmethane diisocyanate in a plant engineered for minimal exposure to diisocyanates. J Allergy Clin Immunol 1993, 92(3):387-396.
32. Sussman G.L., Beezhold D.H., Liss G. Latex allergy: historical perspective. Methods 2002, 27(1):3-9.
33. Mirabelli M.C., Zock J.P., Plana E., et al. Occupational risk factors for asthma among nurses and related healthcare professionals in an international study. Occup Environ Med 2007, 64(7):474-479.
34. Vandenplas O., Larbanois A., Vanassche F., et al. Latex-induced occupational asthma: time trend in incidence and relationship with hospital glove policies. Allergy 2009, 64(3):415-420.
35. Armentia A., Martin-Santos J.M., Quintero A., et al. Bakers' asthma: prevalence and evaluation of immunotherapy with a wheat flour extract. Ann Allergy 1990, 65(4):265-272.
36. Patouchas D., Efremidis G., Karkoulias K., et al. Lung function measurements in traditional bakers. Acta Biomed 2008, 79(3):197-203.
37. Jacobs J.H., Spaan S., van Rooy G.B., et al. Exposure to trichloramine and respiratory symptoms in indoor swimming pool workers. Eur Respir J 2007, 29(4):690-698.
38. Hur G.Y., Koh D.H., Kim H.A., et al. Prevalence of work-related symptoms and serum-specific antibodies to wheat flour in exposed workers in the bakery industry. Respir Med 2008, 102(4):548-555.
39. Susitaival P., Kirk J.H., Schenker M.B. Atopic symptoms among California veterinarians. Am J Ind Med 2003, 44(2):166-171.
40. Lutsky I., Baum G.L., Teichtahl H., et al. Occupational respiratory disease in veterinarians. Ann Allergy 1985, 55(2):153-156.
41. Food and Agriculture Organization of the United Nations.Fisheries Dept The state of world fisheries and aquaculture 2009, Food and Agriculture Organization of the United Nations, Rome (Italy), p. v.
42. Jeebhay M.F., Robins T.G., Lehrer S.B., et al. Occupational seafood allergy: a review. Occup Environ Med 2001, 58(9):553-562.
43. Jeebhay M.F., Cartier A. Seafood workers and respiratory disease: an update. Curr Opin Allergy Clin Immunol 2010, 10(2):104-113.
44. Ohtsuka T., Tsuboi S., Katsutani T., et al. Arerugi 1993, 42(3 Pt 1):214-218. [in Japanese].
45. Platts-Mills T.A., Vervloet D., Thomas W.R., et al. Indoor allergens and asthma: report of the Third International Workshop. J Allergy Clin Immunol 1997, 100(6 Pt 1):S2-S24.
46. Medina-Ramon M., Zock J.P., Kogevinas M., et al. Asthma symptoms in women employed in domestic cleaning: a community based study. Thorax 2003, 58(11):950-954.
47. Obadia M., Liss G.M., Lou W., et al. Relationships between asthma and work exposures among non-domestic cleaners in Ontario. Am J Ind Med 2009, 52(9):716-723.
48. Flindt M.L. Pulmonary disease due to inhalation of derivatives of Bacillus subtilis containing proteolytic enzyme. Lancet 1969, 1(7607):1177-1181.
49. Pepys J., Longbottom J.L., Hargreave F.E., et al. Allergic reactions of the lungs to enzymes of Bacillus subtilis. Lancet 1969, 1(7607):1181-1184.
50. Cathcart M., Nicholson P., Roberts D., et al. Enzyme exposure, smoking and lung function in employees in the detergent industry over 20 years. Medical Subcommittee of the UK Soap and Detergent Industry Association. Occup Med (Lond) 1997, 47(8):473-478.
51. Schweigert M.K., Mackenzie D.P., Sarlo K. Occupational asthma and allergy associated with the use of enzymes in the detergent industry-a review of the epidemiology, toxicology and methods of prevention. Clin Exp Allergy 2000, 30(11):1511-1518.
52. Grammer L.C., Harris K.E., et al. Effect of respiratory protective devices on development of antibody and occupational asthma to an acid anhydride. Chest 2002, 121(4):1317-1322.
53. Jaakkola M.S., Jaakkola J.J. Impact of smoke-free workplace legislation on exposures and health: possibilities for prevention. Eur Respir J 2006, 28(2):397-408.
54. Schoj V., Alderete M., Ruiz E., et al. The impact of a 100% smoke-free law on the health of hospitality workers from the city of Neuquen, Argentina. Tob Control 2010, 19(2):134-137.
55. Massin N., Bohadana A.B., Wild P., et al. Respiratory symptoms and bronchial responsiveness in lifeguards exposed to nitrogen trichloride in indoor swimming pools. Occup Environ Med 1998, 55(4):258-263.
56. Nemery B., Hoet P.H., Nowak D. Indoor swimming pools, water chlorination and respiratory health. Eur Respir J 2002, 19(5):790-793.
57. Thickett K.M., McCoach J.S., Gerber J.M., et al. Occupational asthma caused by chloramines in indoor swimming-pool air. Eur Respir J 2002, 19(5):827-832.
58. Fantuzzi G., Righi E., Predieri G., et al. Prevalence of ocular, respiratory and cutaneous symptoms in indoor swimming pool workers and exposure to disinfection by-products (DBPs). Int J Environ Res Public Health 2010, 7(4):1379-1391.
59. Baur X. I are we closer to developing threshold limit values for allergens in the workplace?. Ann Allergy Asthma Immunol 2003, 90(5 Suppl 2):11-18.
60. Gautrin D., Ghezzo H., Infante-Rivard C., et al. Long-term outcomes in a prospective cohort of apprentices exposed to high-molecular-weight agents. Am J Respir Crit Care Med 2008, 177(8):871-879.
61. LaMontagne A.D., Radi S., Elder D.S., et al. Primary prevention of latex related sensitisation and occupational asthma: a systematic review. Occup Environ Med 2006, 63(5):359-364.
62. Anees W., Moore V.C., Burge P.S. FEV1 decline in occupational asthma. Thorax 2006, 61(9):751-755.